Andy Chen, M.D., Ph.D.

Head Shot of Andy Chen
click here
503 494-5058


Dr. Chen provides care for patients with hematologic malignancies, particularly those with lymphoma or who are undergoing transplant. He has a basic science background in immunology, and his research now focuses on clinical trials of novel therapies and transplantation for aggressive lymphoma.

Summary of Current Research

Selected Publications

"Improved outcome with busulfan, melphalan and thiotepa conditioning in autologous hematopoietic stem cell transplant for relapsed/refractory Hodgkin lymphoma," Leukemia and Lymphoma (Vol: 55, Issue: 3, Page 583-587) - 2014

"Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement," British Journal of Haematology (Vol: 162, Issue: 5, Page 648-656) - 2013

"Clinical experience with a simple algorithm for plerixafor utilization in autologous stem cell mobilization," Bone Marrow Transplantation (Vol: 47, Issue: 12, Page 1526-1529) - 2012

"Tandem chemo-mobilization followed by high-dose melphalan and carmustine with single autologous hematopoietic cell transplantation for multiple myeloma," Bone Marrow Transplantation (Vol: 47, Issue: 4, Page 516-521) - 2012

"Pre-transplant evaluation," Blood and Marrow Transplant Handbook: Comprehensive Guide for Patient Care ( Page 27-37) - 2011


OHSU Knight Cancer Institute

Visit Our Site

For Healthcare Professionals


  Email Andy Chen

503 494-5058

Memberships & Associations

American Society of Hematology American Society of Clinical Oncology American Society of Blood and Marrow Transplantation